Loading...

Alvotech

ALVONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$9.61
$0.45(4.91%)

Alvotech (ALVO) Financial Performance & Income Statement Overview

Review Alvotech’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
435.56%
435.56%
Operating Income Growth
119.63%
119.63%
Net Income Growth
57.98%
57.98%
Operating Cash Flow Growth
24.13%
24.13%
Operating Margin
21.97%
21.97%
Gross Margin
60.59%
60.59%
Net Profit Margin
16.49%
16.49%
ROE
-23.20%
23.20%
ROIC
13.13%
13.13%

Alvotech (ALVO) Income Statement & Financial Overview

Review Alvotech's (ALVO) income statement with detailed quarterly and annual figures.

MetricQ3 2024Q2 2024Q1 2024Q4 2023
Revenue$102.89M$198.75M$12.43M$53.39M
Cost of Revenue$39.81M$45.21M$19.96M$56.42M
Gross Profit$63.08M$153.54M-$7.53M-$3.03M
Gross Profit Ratio$0.61$0.77-$0.61-$0.06
R&D Expenses$33.57M$47.61M$49.87M$58.01M
SG&A Expenses$16.88M$14.07M$15.49M$18.001M
Operating Expenses$50.35M$61.68M$65.36M$74.12M
Total Costs & Expenses$90.16M$106.89M$85.31M$130.54M
Interest Income$77.37M$80.04M$783000.00$0.00
Interest Expense$90.68M$42.05M$184.06M$68.56M
Depreciation & Amortization$8.40M$7.56M$7.19M$6.72M
EBITDA$138.22M-$16.60M-$33.91M-$139.57M
EBITDA Ratio$1.34-$0.08-$5.29-$2.19
Operating Income$12.73M$91.87M-$72.88M-$77.15M
Operating Income Ratio$0.12$0.46-$5.86-$1.45
Other Income/Expenses (Net)-$37.48M-$15.07M-$176.75M-$231.65M
Income Before Tax-$24.75M$76.80M-$225.17M-$308.80M
Income Before Tax Ratio-$0.24$0.39-$18.11-$5.78
Income Tax Expense-$13.36M$11.57M-$6.44M-$32.24M
Net Income-$11.39M$65.22M-$218.73M-$276.56M
Net Income Ratio-$0.11$0.33-$17.60-$5.18
EPS$0.00$0.25-$0.82-$1.04
Diluted EPS$0.00$0.25-$0.82-$1.04
Weighted Avg Shares Outstanding$0.00$258.67M$266.82M$266.82M
Weighted Avg Shares Outstanding (Diluted)$0.00$258.67M$266.82M$266.82M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;